LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Relative Growth Rate Standard Error of the Mean for Relative Growth Rate
BT-20 SB590885
3.33
uM
LJP5
1.0468 0.0126 1.0677 0.0178
BT-20 PIK-93
3.33
uM
LJP5
0.8046 0.0200 0.7178 0.0248
BT-20 KIN001-043
3.33
uM
LJP6
0.9453 0.0360 0.9217 0.0505
BT-20 Alpelisib
3.33
uM
LJP5
0.3779 0.0262 0.0997 0.0230
BT-20 Luminespib
3.33
uM
LJP5
0.2896 0.0234 -0.0307 0.0539
BT-20 A443654
3.33
uM
LJP6
0.1787 0.0271 -0.1893 0.0296
BT-20 OSI-027
3.33
uM
LJP6
0.4965 0.0396 0.2726 0.0437
BT-20 XMD11-85h
3.33
uM
LJP6
0.8896 0.0523 0.8423 0.0727
BT-20 HG-6-64-01
3.33
uM
LJP6
0.5003 0.0431 0.2774 0.0530
BT-20 WH-4-025
3.33
uM
LJP5
0.3900 0.0660 0.1174 0.0897
BT-20 WZ-4-145
3.33
uM
LJP6
0.7452 0.1095 0.6364 0.1522
BT-20 XMD16-144
3.33
uM
LJP5
0.3365 0.0155 0.0376 0.0416
BT-20 Brivanib
3.33
uM
LJP5
0.9520 0.0247 0.9311 0.0352
BT-20 Buparlisib
3.33
uM
LJP5
0.1847 0.0157 -0.1823 0.0459
BT-20 BX-912
3.33
uM
LJP5
0.8828 0.0605 0.8300 0.0863
BT-20 Canertinib
3.33
uM
LJP6
0.7545 0.0358 0.6463 0.0457
BT-20 Celastrol
3.33
uM
LJP6
0.1905 0.0498 -0.1703 0.0499
BT-20 CGP60474
3.33
uM
LJP5
0.1646 0.0438 -0.2125 0.0831
BT-20 CGP60474
3.33
uM
LJP6
0.1269 0.0278 -0.2668 0.0643
BT-20 CHIR-99021
3.33
uM
LJP6
0.9848 0.0352 0.9796 0.0503
BT-20 CP724714
3.33
uM
LJP5
0.8211 0.0298 0.7424 0.0385
BT-20 CP466722
3.33
uM
LJP5
0.9752 0.0232 0.9653 0.0331
BT-20 Crizotinib
3.33
uM
LJP5
0.5485 0.0692 0.3473 0.0934
BT-20 Momelotinib
3.33
uM
LJP5
0.6748 0.0397 0.5310 0.0490
BT-20 Dasatinib
3.33
uM
LJP5
0.2964 0.0274 -0.0190 0.0355